Related references
Note: Only part of the references are listed.Privileged scaffold-based design to identify a novel drug-like 5-HT7 receptor-preferring agonist to target Fragile X syndrome
Enza Lacivita et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Revisit ligand-receptor interaction at the human vasopressin V 2 receptor: A kinetic perspective
Chunji Liu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Ligand with Two Modes of Interaction with the Dopamine D2 Receptor-An Induced-Fit Mechanism of Insurmountable Antagonism
Richard Agren et al.
ACS CHEMICAL NEUROSCIENCE (2020)
(S)-5-(2′-Fluorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydronaphthalen-2-amine, a Serotonin Receptor Modulator, Possesses Anticonvulsant, Prosocial, and Anxiolytic-like Properties in an Fmr1 Knockout Mouse Model of Fragile X Syndrome and Autism Spectrum Disorder
Jessica L. Armstrong et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Binding kinetics of ligands acting at GPCRs
David A. Sykes et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2019)
Route to Prolonged Residence Time at the Histamine H1 Receptor: Growing from Desloratadine to Rupatadine
Reggie Bosma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
The microRNA-29a Modulates Serotonin 5-HT7 Receptor Expression and Its Effects on Hippocampal Neuronal Morphology
Floriana Volpicelli et al.
MOLECULAR NEUROBIOLOGY (2019)
Allosteric Inhibition of Serotonin 5-HT7 Receptors by Zinc Ions
Grzegorz Satala et al.
MOLECULAR NEUROBIOLOGY (2018)
Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs
John D. McCorvy et al.
NATURE CHEMICAL BIOLOGY (2018)
GPCRdb in 2018: adding GPCR structure models and ligands
Gaspar Pandy-Szekeres et al.
NUCLEIC ACIDS RESEARCH (2018)
Structure-kinetic relationship studies of cannabinoid CB2 receptor agonists reveal substituent-specific lipophilic effects on residence time
Marjolein Soethoudt et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Structure-Activity Relationships and Therapeutic Potentials of 5-HT7 Receptor Ligands: An Update
Maria N. Modica et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Mordred: a molecular descriptor calculator
Hirotomo Moriwaki et al.
JOURNAL OF CHEMINFORMATICS (2018)
Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone
Sheng Wang et al.
NATURE (2018)
Prediction of Drug-Target Binding Kinetics by Comparative Binding Energy Analysis
Gaurav K. Ganotra et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Activation of Serotonin 5-HT7 Receptors Modulates Hippocampal Synaptic Plasticity by Stimulation of Adenylate Cyclases and Rescues Learning and Behavior in a Mouse Model of Fragile X Syndrome
Lara Costa et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
A comprehensive map of molecular drug targets
Rita Santos et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Structure-Affinity Relationships and Structure-Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A3 Receptor Antagonists
Lizi Xia et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Serotonin 5-HT7 receptor increases the density of dendritic spines and facilitates synaptogenesis in forebrain neurons
Luisa Speranza et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Stimulation of the brain serotonin receptor 7 rescues mitochondrial dysfunction in female mice from two models of Rett syndrome
Daniela Valenti et al.
NEUROPHARMACOLOGY (2017)
Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors
David A. Sykes et al.
NATURE COMMUNICATIONS (2017)
Kinetics for Drug Discovery: an industry-driven effort to target drug residence time
Doris A. Schuetz et al.
DRUG DISCOVERY TODAY (2017)
Crystal Structure of an LSD-Bound Human Serotonin Receptor
Daniel Wacker et al.
CELL (2017)
The drug-target residence time model: a 10-year retrospective
Robert A. Copeland
NATURE REVIEWS DRUG DISCOVERY (2016)
Impact, determination and prediction of drug-receptor residence times for GPCRs
Christofer S. Tautermann
CURRENT OPINION IN PHARMACOLOGY (2016)
Can residence time offer a useful strategy to target agonist drugs for sustained GPCR responses?
J. Daniel Hothersall et al.
DRUG DISCOVERY TODAY (2016)
Toward High-Throughput Predictive Modeling of Protein Binding/Unbinding Kinetics
See Hong Chiu et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2016)
Constructing Interconsistent, Reasonable, and Predictive Models for Both the Kinetic and Thermodynamic Properties of HIV-1 Protease Inhibitors
Sujun Qu et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2016)
In vivo Target Residence Time and Kinetic Selectivity: The Association Rate Constant as Determinant
Wilhelmus E. A. de Witte et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Targeting the Serotonin 5-HT7 Receptor in the Search for Treatments for CNS Disorders: Rationale and Progress to Date
Agnieszka Nikiforuk
CNS DRUGS (2015)
When structure-affinity relationships meet structure-kinetics relationships: 3-((Inden-1-yl)amino)-1-isopropyl-cyclopentane-1-carboxamides as CCR2 antagonists
Maris Vilums et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Structure-Affinity Relationships (SARs) and Structure-Kinetics Relationships (SKRs) of Kv11.1 Blockers
Zhiyi Yu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Kinetics of protein-ligand unbinding: Predicting pathways, rates, and rate-limiting steps
Pratyush Tiwary et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Activation of 5-HT7 receptor stimulates neurite elongation through mTOR, Cdc42 and actin filaments dynamics
Luisa Speranza et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2015)
Ligand Residence Time at G-protein-Coupled Receptors-Why We Should Take Our Time To Study It
C. Hoffmann et al.
MOLECULAR PHARMACOLOGY (2015)
Design, synthesis, radiolabeling and in vivo evaluation of potential positron emission tomography (PET) radioligands for brain imaging of the 5-HT7 receptor
Enza Lacivita et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Synthesis, radiolabeling and in vivo evaluation of [11C](R)-1-[4-[2-(4-methoxyphenyl)phenyl piperazin-1-yl]-3-(2-pyrazinyloxy)-2-propanol, a potential PET radioligand for the 5-HT7 receptor
Hanne D. Hansen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Impact of Template Choice on Homology Model Efficiency in Virtual Screening
Krzysztof Rataj et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Drug-Target Residence Time-A Case for G Protein-Coupled Receptors
Dong Guo et al.
MEDICINAL RESEARCH REVIEWS (2014)
Pharmacological Stimulation of the Brain Serotonin Receptor 7 as a Novel Therapeutic Approach for Rett Syndrome
Bianca De Filippis et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Molecular determinants of drug-receptor binding kinetics
Albert C. Pan et al.
DRUG DISCOVERY TODAY (2013)
Pharmacokinetics and the drug-target residence time concept
Goran Dahl et al.
DRUG DISCOVERY TODAY (2013)
The serotonin receptor 7 promotes neurite outgrowth via ERK and Cdk5 signaling pathways
L. Speranza et al.
NEUROPHARMACOLOGY (2013)
Activation of 5-HT7 Serotonin Receptors Reverses Metabotropic Glutamate Receptor-Mediated Synaptic Plasticity in Wild-Type and Fmr1 Knockout Mice, a Model of Fragile X Syndrome
Lara Costa et al.
BIOLOGICAL PSYCHIATRY (2012)
Slow receptor dissociation is not a key factor in the duration of action of inhaled long-acting ß2-adrenoceptor agonists
David A. Sykes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Target-drug interactions: first principles and their application to drug discovery
Sara Nunez et al.
DRUG DISCOVERY TODAY (2012)
5-HT7R/G12 Signaling Regulates Neuronal Morphology and Function in an Age-Dependent Manner
Fritz Kobe et al.
JOURNAL OF NEUROSCIENCE (2012)
Molecular properties affecting fast dissociation from the D2 receptor
Gary Tresadern et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Markov models of molecular kinetics: Generation and validation
Jan-Hendrik Prinz et al.
JOURNAL OF CHEMICAL PHYSICS (2011)
LP-211 is a brain penetrant selective agonist for the serotonin 5-HT7 receptor
Peter B. Hedlund et al.
NEUROSCIENCE LETTERS (2010)
Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M3 receptor
Mark R. Dowling et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
A temperature accelerated method for sampling free energy and determining reaction pathways in rare events simulations
Luca Maragliano et al.
CHEMICAL PHYSICS LETTERS (2006)
Share Paper
